Melanie Huttenrauch

Von Siebold Str. 5
Goettingen, NI 37075, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Effect of the Ketone Body, D-β-Hydroxybutyrate, on Sirtuin2-Mediated Regulation of Mitochondrial Quality Control and the Autophagy-Lysosomal Pathway.

Effect of the Ketone Body, D-β-Hydroxybutyrate, on Sirtuin2-Mediated Regulation of Mitochondrial Quality Control and the Autophagy-Lysosomal Pathway.

Journal: Cells

Published: December 21, 2022

How mind-body therapies might reduce pathological features of Alzheimer's disease.

How mind-body therapies might reduce pathological features of Alzheimer's disease.

Journal: Neural regeneration research

Published: January 12, 2022

Connecting Mind-Body Therapy-Mediated Effects to Pathological Features of Alzheimer's Disease.

Connecting Mind-Body Therapy-Mediated Effects to Pathological Features of Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: October 12, 2020

Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.

Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.

Journal: Acta neuropathologica communications

Published: August 28, 2018

A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease.

A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease.

Journal: Alzheimer's research & therapy

Published: June 28, 2018

The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease.

The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease.

Journal: Acta neuropathologica

Published: June 06, 2018

Limited Effects of Prolonged Environmental Enrichment on the Pathology of 5XFAD Mice.

Limited Effects of Prolonged Environmental Enrichment on the Pathology of 5XFAD Mice.

Journal: Molecular neurobiology

Published: June 27, 2016

Effects of Long-Term Environmental Enrichment on Anxiety, Memory, Hippocampal Plasticity and Overall Brain Gene Expression in C57BL6 Mice.

Effects of Long-Term Environmental Enrichment on Anxiety, Memory, Hippocampal Plasticity and Overall Brain Gene Expression in C57BL6 Mice.

Journal: Frontiers in molecular neuroscience

Published: June 03, 2016

Physical activity delays hippocampal neurodegeneration and rescues memory deficits in an Alzheimer disease mouse model.

Physical activity delays hippocampal neurodegeneration and rescues memory deficits in an Alzheimer disease mouse model.

Journal: Translational psychiatry

Published: February 26, 2016

Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.

Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: December 08, 2015

Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.

Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD

Published: November 20, 2014

Axonal degeneration in an Alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal Aβ accumulation.

Axonal degeneration in an Alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal Aβ accumulation.

Journal: Frontiers in aging neuroscience

Published: May 08, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026